Gene · 1033
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HYKYHT: A versatile, affordable, and open-source 3D-printed liquid aspiration system. | HardwareX | 2024 | 38327676 | PubTator, text mining | PubMed |
| Characterization of hypoxia-responsive states in ovarian cancer to identify hot tumors and aid adjuvant therapy. | Discov Oncol | 2024 | 38294583 | PubTator, text mining | PubMed |
| SIRT3/6: an amazing challenge and opportunity in the fight against fibrosis and aging. | Cell Mol Life Sci | 2024 | 38294557 | PubTator, text mining | PubMed |
| Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation. | Int J Mol Sci | 2024 | 38279330 | PubTator, text mining | PubMed |
| Acute-on-Chronic Liver Failure Incited by Cyclin-Dependent Kinase Inhibitor Therapy for Breast Cancer Effectively Treated With Liver Transplantation. | ACG Case Rep J | 2024 | 38274302 | PubTator, text mining | PubMed |
| Curcumin for Treating Breast Cancer: A Review of Molecular Mechanisms, Combinations with Anticancer Drugs, and Nanosystems. | Pharmaceutics | 2024 | 38258090 | PubTator, text mining | PubMed |
| Role of Cannabinoids in Oral Cancer. | Int J Mol Sci | 2024 | 38256042 | PubTator, text mining | PubMed |
| p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients. | Int J Mol Sci | 2024 | 38255799 | PubTator, text mining | PubMed |
| PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro. | Cancers (Basel) | 2024 | 38254859 | PubTator, text mining | PubMed |
| Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer. | Cancers (Basel) | 2024 | 38254738 | PubTator, text mining | PubMed |
| Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma. | Sci Rep | 2024 | 38243040 | PubTator, text mining | PubMed |
| Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives. | iScience | 2024 | 38235331 | PubTator, text mining | PubMed |
| Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection. | PLoS Pathog | 2024 | 38232124 | PubTator, text mining | PubMed |
| Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy. | Mol Cancer | 2024 | 38195537 | PubTator, text mining | PubMed |
| ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma. | Int J Biol Sci | 2024 | 38169650 | PubTator, text mining | PubMed |
| Machine learning-driven identification of the gene-expression signature associated with a persistent multiple organ dysfunction trajectory in critical illness. | EBioMedicine | 2024 | 38142638 | PubTator, text mining | PubMed |
| Retraction: YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway. | Int J Cancer | 2024 | 38059668 | PubTator, text mining | PubMed |
| Identification of hypoxia-related gene signatures based on multi-omics analysis in lung adenocarcinoma. | J Cell Mol Med | 2024 | 38013642 | PubTator, text mining | PubMed |
| Cell cycle-dependent gene networks for cell proliferation activated by nuclear CK2α complexes. | Life Sci Alliance | 2024 | 37907238 | PubTator, text mining | PubMed |
| Inter-relationships between suicidality and depressive symptoms among children and adolescents experiencing crisis: A network perspective. | J Affect Disord | 2024 | 37827255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1033/papers?page=10